title: Does the risk exceed the benefit for anticoagulation in end-stage renal disease patients with nonrheumatic atrial fibrillation?
authors.affiliation: VA North Texas Health Care System, UT Southwestern Medical Center at Dallas, Dallas, Texas 75216, USA.
authors.forename: Venkata
authors.initials: V
authors.lastname: Yalamanchili
authors.forename: Robert F
authors.initials: RF
authors.lastname: Reilly
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000150:complications* / Q000188:drug therapy*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications*; D018570:Risk Assessment
chemical_list: D000925:Anticoagulants